In this article

CVS

Follow your favorite stocks CREATE FREE ACCOUNT

CNBC's Jim Cramer on Monday told investors why he's optimistic about CVS , even as the healthcare sector as a whole has lagged this year.

"[It's] fixing its most problematic business, managed care, and seeing real strength in other parts of the business, especially the pharmacy side, where it is the last man standing," he said. "Plus, given the cheapness of the stock, generosity of the dividend yield — here's what I'm saying: buy CVS."

Biopharmaceutical stocks have declined in recent months as the drug makers struggle to adapt to the Trump administration, especially with vaccine-skeptic Robert F. Kennedy Jr. leading the Department of Health and Human Services, Cramer said. The companies are also worrie

See Full Page